EFG
ORGO icon

Ethos Financial Group’s Organogenesis Holdings ORGO Stock Holding History

Ethos Financial Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.6K Hold
12,987
– – ﹤0.01% 630
2026
Q1 		$67.3K Hold
12,987
– – ﹤0.01% 526
2025
Q4 		$67.3K Buy
+12,987
New +$62.9K 0.01% 513

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ethos Financial Group's ORGO Position: Q2 2026 in Review

Ethos Financial Group held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 12,987 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

Ethos Financial Group first reported a position in ORGO in Q4 2025 and has held it in 3 quarters since. The position peaked at $67.3K in Q1 2026. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Ethos Financial Group held 12,987 shares of Organogenesis Holdings worth $31.6K as of Q2 2026.
  • Ethos Financial Group left its Organogenesis Holdings share count unchanged in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Ethos Financial Group's portfolio in Q2 2026, its #630 holding.
  • Ethos Financial Group first reported a position in Organogenesis Holdings in Q4 2025 and has held it in 3 quarters since.
  • Ethos Financial Group's Organogenesis Holdings position peaked at $67.3K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.